These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23638266)

  • 1. CD4 testing at clinics to assess eligibility for antiretroviral therapy.
    Lumala R; van den Akker T; Metcalf CA; Diggle E; Zamadenga B; Mbewa K; Akkeson A
    Malawi Med J; 2012 Jun; 24(2):25-8. PubMed ID: 23638266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries.
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Wanjala S; Masiku C; Szumilin E; Etard JF; Davies MA; Maman D
    PLoS One; 2018; 13(11):e0207656. PubMed ID: 30475865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the need for antiretroviral treatment and an assessment of a simplified HIV/AIDS case definition in rural Malawi.
    McGrath N; Kranzer K; Saul J; Crampin AC; Malema S; Kachiwanda L; Zaba B; Jahn A; Fine PE; Glynn JR
    AIDS; 2007 Nov; 21 Suppl 6(Suppl 6):S105-13. PubMed ID: 18032933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South Africa.
    Patten GE; Wilkinson L; Conradie K; Isaakidis P; Harries AD; Edginton ME; De Azevedo V; van Cutsem G
    J Int AIDS Soc; 2013 Jul; 16(1):18518. PubMed ID: 23830642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ART initiation in an outpatient treatment center in Dakar, Senegal: A retrospective cohort analysis (1998-2015).
    Ngom NF; Faye MA; Ndiaye K; Thiam A; Ndour CT; Etard JF; Sow PS; Seydi M; Delaporte E; Cournil A
    PLoS One; 2018; 13(9):e0202984. PubMed ID: 30231075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of laboratory test utilization for HIV/AIDS care in urban ART clinics of Lilongwe, Malawi.
    Palchaudhuri S; Tweya H; Hosseinipour M
    Malawi Med J; 2014 Jun; 26(2):42-4. PubMed ID: 25157316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting CD4 testing to a clinical subgroup of patients could limit unnecessary CD4 measurements, premature antiretroviral treatment and costs in Thyolo District, Malawi.
    Zachariah R; Teck R; Ascurra O; Humblet P; Harries AD
    Trans R Soc Trop Med Hyg; 2006 Jan; 100(1):24-31. PubMed ID: 16202436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO clinical staging of HIV infection and disease, tuberculosis and eligibility for antiretroviral treatment: relationship to CD4 lymphocyte counts.
    Teck R; Ascurra O; Gomani P; Manzi M; Pasulani O; Kusamale J; Salaniponi FM; Humblet P; Nunn P; Scano F; Harries AD; Zachariah R
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):258-62. PubMed ID: 15786887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal patterns of provider initiated HIV testing and counselling, antiretroviral therapy eligibility assessment and referral in primary health clinic attendees in Blantyre, Malawi.
    MacPherson P; Lalloo DG; Choko AT; Mann GH; Squire SB; Mwale D; Manda E; Makombe SD; Desmond N; Heyderman R; Corbett EL
    Trop Med Int Health; 2012 Apr; 17(4):507-17. PubMed ID: 22296187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening HIV-infected adults in Malawi for anaemia: impact on eligibility for antiretroviral therapy.
    Page ID; McKew SJ; Kudzala AG; Fullwood C; van Oosterhout JJ; Bates I
    Int J STD AIDS; 2013 Jun; 24(6):449-53. PubMed ID: 23970747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa.
    Kranzer K; Zeinecker J; Ginsberg P; Orrell C; Kalawe NN; Lawn SD; Bekker LG; Wood R
    PLoS One; 2010 Nov; 5(11):e13801. PubMed ID: 21072191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The most efficient use of resources to identify those in need of antiretroviral treatment in Africa: empirical data from Côte d'Ivoire's Drug Access Initiative.
    Diomandé FV; Bissagnéné E; Nkengasong JN; Maurice C; Monga B; Laga M; Nolan ML
    AIDS; 2003 Jul; 17 Suppl 3():S87-93. PubMed ID: 14565614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral treatment scale-up among persons living with HIV in Kenya: results from a nationally representative survey.
    Odhiambo JO; Kellogg TA; Kim AA; Ng'ang'a L; Mukui I; Umuro M; Mohammed I; De Cock KM; Kimanga DO; Schwarcz S;
    J Acquir Immune Defic Syndr; 2014 May; 66 Suppl 1(Suppl 1):S116-22. PubMed ID: 24732815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with timely initiation of antiretroviral therapy in two HIV clinics in Lilongwe, Malawi.
    Johnson DC; Feldacker C; Tweya H; Phiri S; Hosseinipour MC
    Int J STD AIDS; 2013 Jan; 24(1):42-9. PubMed ID: 23467293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy (ART) rationing and access mechanisms and their impact on youth ART utilization in Malawi.
    Dixon JG; Gibson S; McPake B; Maleta K
    Malawi Med J; 2011 Jun; 23(2):48-54. PubMed ID: 23074812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
    Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
    AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Goemaere E; Wanjala S; Masiku C; Szumilin E; Etard JF; Maman D; Davies MA
    Glob Health Action; 2019; 12(1):1679472. PubMed ID: 31679482
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
    Siegfried N; Uthman OA; Rutherford GW
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with loss to clinic among HIV patients not yet known to be eligible for antiretroviral therapy (ART) in Mozambique.
    Pati R; Lahuerta M; Elul B; Okamura M; Alvim MF; Schackman B; Bang H; Fernandes R; Assan A; Lima J; Nash D;
    J Int AIDS Soc; 2013 Jun; 16(1):18490. PubMed ID: 23755857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.